Eliana Merle
Stock Analyst at UBS
(2.30)
# 1,511
Out of 4,941 analysts
93
Total ratings
41.18%
Success rate
-0.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAPT RAPT Therapeutics | Maintains: Neutral | $8 → $9 | $10.75 | -16.28% | 4 | Aug 12, 2025 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $458 → $523 | $371.59 | +40.75% | 5 | Aug 12, 2025 | |
| ANAB AnaptysBio | Maintains: Neutral | $18 → $20 | $20.62 | -3.01% | 5 | Aug 12, 2025 | |
| ASND Ascendis Pharma | Maintains: Buy | $306 → $307 | $191.85 | +60.02% | 2 | Aug 8, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $113 → $114 | $57.39 | +98.64% | 3 | Aug 5, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $403 → $550 | $432.00 | +27.31% | 3 | Aug 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Neutral | $45 → $12 | $19.68 | -39.02% | 1 | Jul 21, 2025 | |
| PROK ProKidney | Maintains: Buy | $4 → $8 | $2.35 | +240.43% | 1 | Jul 15, 2025 | |
| CVAC CureVac | Downgrades: Neutral | $12 → $5.5 | $5.53 | -0.45% | 3 | Jun 26, 2025 | |
| ARVN Arvinas | Maintains: Buy | $74 → $21 | $7.09 | +196.19% | 4 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $70 | $41.43 | +68.96% | 3 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $70 | $26.82 | +161.00% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $72 | $50.01 | +43.97% | 3 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $44 | $25.54 | +72.28% | 8 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $38 | $9.47 | +301.27% | 3 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $109 | $48.52 | +124.65% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $2.2 | $1.51 | +46.18% | 4 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $71 | $35.94 | +97.55% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.93 | +156.18% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $9.82 | +22.20% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $3 | $3.70 | -18.92% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $3.85 | +576.20% | 1 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $97 → $131 | $112.72 | +16.22% | 6 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $5 | $8.95 | -44.13% | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $18 | $6.59 | +173.14% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $42 | $14.84 | +183.02% | 4 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $8 | $1.96 | +308.16% | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.54 | +384.58% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $47 | $9.07 | +418.19% | 1 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $7.17 | +123.15% | 2 | May 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $192 → $134 | $32.41 | +313.45% | 3 | Aug 19, 2020 |
RAPT Therapeutics
Aug 12, 2025
Maintains: Neutral
Price Target: $8 → $9
Current: $10.75
Upside: -16.28%
Madrigal Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $458 → $523
Current: $371.59
Upside: +40.75%
AnaptysBio
Aug 12, 2025
Maintains: Neutral
Price Target: $18 → $20
Current: $20.62
Upside: -3.01%
Ascendis Pharma
Aug 8, 2025
Maintains: Buy
Price Target: $306 → $307
Current: $191.85
Upside: +60.02%
BioMarin Pharmaceutical
Aug 5, 2025
Maintains: Buy
Price Target: $113 → $114
Current: $57.39
Upside: +98.64%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $403 → $550
Current: $432.00
Upside: +27.31%
Sarepta Therapeutics
Jul 21, 2025
Downgrades: Neutral
Price Target: $45 → $12
Current: $19.68
Upside: -39.02%
ProKidney
Jul 15, 2025
Maintains: Buy
Price Target: $4 → $8
Current: $2.35
Upside: +240.43%
CureVac
Jun 26, 2025
Downgrades: Neutral
Price Target: $12 → $5.5
Current: $5.53
Upside: -0.45%
Arvinas
May 15, 2025
Maintains: Buy
Price Target: $74 → $21
Current: $7.09
Upside: +196.19%
May 13, 2025
Maintains: Buy
Price Target: $72 → $70
Current: $41.43
Upside: +68.96%
May 2, 2025
Maintains: Buy
Price Target: $78 → $70
Current: $26.82
Upside: +161.00%
Apr 30, 2025
Maintains: Buy
Price Target: $65 → $72
Current: $50.01
Upside: +43.97%
Apr 29, 2025
Initiates: Overweight
Price Target: $44
Current: $25.54
Upside: +72.28%
Jan 31, 2025
Maintains: Buy
Price Target: $25 → $38
Current: $9.47
Upside: +301.27%
Jan 31, 2025
Maintains: Buy
Price Target: $42 → $109
Current: $48.52
Upside: +124.65%
Jan 28, 2025
Maintains: Neutral
Price Target: $5 → $2.2
Current: $1.51
Upside: +46.18%
Jan 8, 2025
Maintains: Buy
Price Target: $65 → $71
Current: $35.94
Upside: +97.55%
Jan 7, 2025
Initiates: Buy
Price Target: $28
Current: $10.93
Upside: +156.18%
Nov 12, 2024
Initiates: Buy
Price Target: $12
Current: $9.82
Upside: +22.20%
Nov 12, 2024
Initiates: Neutral
Price Target: $3
Current: $3.70
Upside: -18.92%
Nov 12, 2024
Initiates: Buy
Price Target: $26
Current: $3.85
Upside: +576.20%
Sep 18, 2024
Maintains: Neutral
Price Target: $97 → $131
Current: $112.72
Upside: +16.22%
Apr 4, 2024
Maintains: Neutral
Price Target: $3 → $5
Current: $8.95
Upside: -44.13%
Mar 27, 2024
Maintains: Buy
Price Target: $19 → $18
Current: $6.59
Upside: +173.14%
May 19, 2023
Maintains: Buy
Price Target: $45 → $42
Current: $14.84
Upside: +183.02%
Dec 7, 2022
Maintains: Buy
Price Target: $19 → $8
Current: $1.96
Upside: +308.16%
Oct 13, 2022
Initiates: Buy
Price Target: $22
Current: $4.54
Upside: +384.58%
Jun 23, 2022
Maintains: Buy
Price Target: $51 → $47
Current: $9.07
Upside: +418.19%
May 21, 2021
Initiates: Buy
Price Target: $16
Current: $7.17
Upside: +123.15%
Aug 19, 2020
Maintains: Neutral
Price Target: $192 → $134
Current: $32.41
Upside: +313.45%